Kasabach-Merritt Phenomenon

Pediatric Clinics of North America

Volumn 57, Issue 5, 2010, Pages 1085-1089

  Kelly, Michael ^a,b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b Children's Hospital of Wisconsin ^*  (United States)

Author keywords

Coagulopathy; Kaposiform Hemangioendothelioma; Kasabach Merritt Phenomenon; Thrombocytopenia; Tufted Angioma

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA INTERFERON; AMINOCAPROIC ACID; CORTICOSTEROID; D DIMER; DIPYRIDAMOLE; FRESH FROZEN PLASMA; GLUCOSE TRANSPORTER 1; VINCRISTINE; ANTINEOPLASTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

ANEMIA; ARTIFICIAL EMBOLISM; CRYOPRECIPITATE; ECCHYMOSIS; ERYTHROCYTE TRANSFUSION; HEMANGIOENDOTHELIOMA; HUMAN; HYPOFIBRINOGENEMIA; KASABACH MERRITT SYNDROME; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PROTHROMBIN TIME; REVIEW; SPASTIC PARAPLEGIA; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; THROMBOPLASTIN TIME; TUMOR REGRESSION; VASCULAR TUMOR; DIFFERENTIAL DIAGNOSIS; INFANT; INFANT, NEWBORN, DISEASES; NEWBORN; PATHOPHYSIOLOGY; RISK FACTOR; SYNDROME; VASCULAR NEOPLASMS;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTINEOPLASTIC AGENTS, PHYTOGENIC; DIAGNOSIS, DIFFERENTIAL; HEMANGIOENDOTHELIOMA; HUMANS; INFANT; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; PLATELET TRANSFUSION; RISK FACTORS; SYNDROME; THROMBOCYTOPENIA; VASCULAR NEOPLASMS;

EID: 77957269709     PISSN: 00313955     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pcl.2010.07.006     Document Type: Review

References (26)

1. Kasabach H.H., Merritt K.K. Capillary hemangioma with extensive purpura. Am J Dis Child 1940, 59:1063-1079.
2. Hall G.W. Kasabach-Merritt syndrome: pathogenesis and management. Br J Haematol 2001, 112(4):851-862.
3. Lyons L.L., North P.E., Mac-Moune Lai F., et al. Kaposiform hemangioendothelioma: a study of 33 cases emphasizing its pathologic, immunophenotypic, and biologic uniqueness from juvenile Hemangioma. Am J Surg Pathol 2004, 28(5):559-568.
4. Sarkar M., Mulliken J.B., Kozakewich H.P., et al. Thrombocytopenic coagulopathy (Kasabach-Merritt phenomenon) is associated with Kaposiform hemangioendothelioma and not with common infantile hemangioma. Plast Reconstr Surg 1997, 100(6):1377-1386.
5. Enjolras O., Wassaf M., Mazoyer E., et al. Infants with Kasabach-Merritt syndrome do not have ″ true″ hemangiomas. J Pediatr 1997, 130(4):631-640.
6. Alvarez-Mendoza A., Lourdes T.S., Ridaura-Sanz C., et al. Histopathology of vascular lesions found in Kasabach-Merritt syndrome: review based on 13 cases. Pediatr Dev Pathol 2000, 3(6):556-560.
7. Shim W.K. Hemangiomas of infancy complicated by thrombocytopenia. Am J Surg 1968, 116(6):896-906.
8. Ryan C., Price V., John P., et al. Kasabach-Merritt phenomenon: a single centre experience. Eur J Haematol 2010, 84(2):97-104.
9. Esterly N. Kasabach-Merritt syndrome in infants. J Am Acad Dermatol 1983, 8(4):504-513.
10. Maceyko R., Camisa C. Kasabach-Merritt syndrome. Pediatr Dermatol 1991, 8(2):133-136.
11. Zukerberg L.R., Nickoloff B.J., Weiss S.W. Kaposiform hemangioendothelioma of infancy and childhood. An aggressive neoplasm associated with Kasabach-Merritt syndrome and lymphangiomatosis. Am J Surg Pathol 1993, 17(4):321-328.
12. Rodriquez V., Lee A., Witman P.M., et al. Kasabach-Merritt phenomenon: case series and retrospective review of the mayo clinic experience. J Pediatr Hematol Oncol 2009, 31(7):522-526.
13. Enjolras O., Mulliken B., Wassef M., et al. Residual lesions after Kasabach-Merritt phenomenon in 41 patients. J Am Acad Dermatol 2000, 42(2):225-235.
14. Verheul H.M., Panigrahy D., Flynn E., et al. Treatment of the Kasabach-Merritt syndrome with pegylated recombinant human megakaryocyte growth and development factor in mice: elevated platelet counts, prolonged survival, and tumor growth inhibition. Pediatr Res 1999, 46(5):562-565.
15. Phillips W.G., Marsden J.R. Kasabach-Merritt syndrome exacerbated by platelet transfusion. J R Soc Med 1993, 86:231-232.
16. Pampin C., Devillers A., Treguier C., et al. Intratumoral consumption of indium-111-labeled platelets in a child with splenic hemangioma and thrombocytopenia. J Pediatr Hematol Oncol 2000, 22(3):256-258.
17. Seon K.S., Jin C.S., Gun Y.N., et al. Kasabach-Merritt syndrome: identification of platelet trapping in a tufted angioma by immunohistochemistry technique using monoclonal antibody to CD61. Pediatr Dermatol 1999, 16(5):392-394.
18. Ortel T., Onorato J., Bedrosian C., et al. Antifibrinolytic therapy in the management of the kasabach merritt syndrome. Am J Hematol 1988, 29(1):44-48.
19. Larsen E., Zinkham H., Eggleston C., et al. Kasabach-Merritt syndrome: therapeutic considerations. Pediatrics 1987, 79:971-980.
20. Beaubien E., Ball N., Storwick G. Kaposiform hemangioendothelioma: a locally aggressive vascular tumor. J Am Acad Dermatol 1998, 38(5):799-802.
21. Perez Payarols J., Pardo Masferrer J., Gomez Bellvert C. Treatment of life-threatening infantile hemangiomas with vincristine. N Engl J Med 1995, 333:69-70.
22. Hu B., Lachman R., Phillips J., et al. Kasabach-Merritt syndrome-associated kaposiform hemangioendothelioma successfully treated with cyclophosphamide, vincristine, and actinomycin. D J Pediatr Hematol Oncol 1998, 20(6):567-569.
23. Vin-Christian K., McCalmont T., Frieden I. Kaposiform Hemangioendothelioma: an aggressive, locally invasive vascular tumor that can mimic hemangioma of infancy. Arch Dematol 1997, 133(12):1573-1578.
24. Barlow C., Priebe C. Mulliken, Spastic diplegia as a complication of interferon Alfa-2a treatment of hemangiomas of infancy. J Pediatr 1998, 133(3):527-530.
25. Haisley-Royster C., Enjolras O., Frieden I. Kasabach-Merritt phenomenon: a retrospective study of treatment with vincristine. J Pediatr Hematol Oncol 2002, 24(6):459-462.
26. Ohtsuka T., Saegusa M., Yamakage S. Angioblastoma (Nakagawa) with hyperhidrosis, and relapse after a 10-year interval. Br J Dermatol 2000, 143(1):223-224.